Cyanvac

Industry: Data analytics for personalized medicine

Cyanvac (formerly known as Oncome) is exploring the use of data analytics in personalized cancer medicine. The company has created a test that acquires RNA and DNA data on a tumor sample. Then, using proprietary algorithms, the test maps this genomic data onto a database that links types of cancers to potential therapies.
 
The company has found ways to encourage machine learning in its algorithms and offer better information on how a tumor sample will respond to a given drug.
 
Increasingly, cancer-combatting drugs are designed to target specific mechanisms that may be unique to only one or a few types of cancer. This is driving the use of personalized cancer care, with treatment plans tailored to the individual. Cyanvac’s technology will help doctors design better treatment plans. 

Back to companies